Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Journal of the American Academy of Dermatology|February 28, 2002
Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 monthsS F Friedlander, A A Hebert, D B Allen, et al.Pediatric Dermatology|July 8, 2000
Telangiectasia macularis eruptiva perstansN F Gibbs, S F Friedlander, E F HarpsterJournal of the American Academy of Dermatology|July 30, 1999
Transillumination blisters in a neonateF P Sajben, N F Gibbs, S F FriedlanderThe Journal of Investigative Dermatology|September 1, 1997
Premature termination codon mutations in the type VII collagen gene in recessive dystrophic epidermolysis bullosa result in nonsense-mediated mRNA decay and absence of functional proteinA M Christiano, S Amano, L F Eichenfield, et al.American Journal of Medical Genetics|November 1, 1994
Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy?L M Bird, H F Krous, L F Eichenfield, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 9, 2021
Topical therapy of atopic dermatitis with a focus on pimecrolimusT Luger, A S Paller, A D Irvine, et al.Pediatric Dermatology|November 26, 1999
Neonatal erosions and ulcerations in giant congenital melanocytic neviY C Giam, M L Williams, P E Leboit, et al.Journal of the American Academy of Dermatology|February 1, 1997
Gastric outlet obstruction and epidermolysis bullosaD W Shaw, J D Fine, D J Piacquadio, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2018
Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trialsA B Gottlieb, K Gordon, S Hsu, et al.The British Journal of Dermatology|January 30, 2004
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programmeN Barbier, C Paul, T Luger, et al.Pageof 7